The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Vaginal Health: Insights, Views & Attitudes (VIVA) – results from an international survey
Abstract
OBJECTIVE: To assess knowledge of vaginal atrophy among women using the Vaginal Health: Insights, Views & Attitudes (VIVA) survey. METHODS: A structured online questionnaire was used to obtain information from 3520 postmenopausal women aged 55-65 years living in Great Britain, the United States, Canada, Sweden, Denmark, Finland, and Norway. RESULTS: In total, 45% of women reported experiencing vaginal symptoms. Only 4% of women attributed these symptoms to vaginal atrophy, and 63% failed to recognize vaginal atrophy as a chronic condition. Overall, 44% of respondents did not have a gynecologist, but this percentage varied between countries. Most women (75%) felt that vaginal atrophy had a negative impact on life, but this perception also showed country-specific differences. Most Finnish respondents (76%) were satisfied with the amount of information available about vaginal atrophy, compared with just 37-42% of women from other countries. Most women used over-the-counter products for vaginal atrophy symptoms, but specific means of treating the underlying cause were less well known. Almost half (46%) of all respondents lacked knowledge about local estrogen therapy, with women in Great Britain, the United States and Canada being most likely to lack knowledge of such treatment. Overall, 30% of women would consider taking local estrogen therapy, with vaginal tablets being the preferred option in all countries. CONCLUSION: Postmenopausal women have a low understanding of vaginal atrophy. Medical practitioners should proactively raise this topic, help patients to understand that vaginal atrophy is a chronic condition, and discuss treatment options. Country-specific approaches may be required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A prospective population-based study of menopausal symptoms
Dennerstein, L. (2000) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)00930-3 · Cited by 883
Recommendations for the management of postmenopausal vaginal atrophy
Sturdee, D. W., & Panay, N. (2010) · Climacteric · doi:10.3109/13697137.2010.522875 · Cited by 527
Mac Bride, M. B., Rhodes, D. J., & Shuster, L. T. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0413 · Cited by 444
CARDOZO, L. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00175-6 · Cited by 388
Prevalence and Impact of Vaginal Symptoms Among Postmenopausal Women
Santoro, N., & Komi, J. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01335.x · Cited by 337
Women's voices in the menopause: Results from an international survey on vaginal atrophy
Nappi, R. E., & Kokot-Kierepa, M. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.08.001 · Cited by 302
Self-citationLevine, K. B., Williams, R. E., & Hartmann, K. E. (2008) · Menopause · doi:10.1097/gme.0b013e31815a5168 · Cited by 296
Menopause and sexuality: Prevalence of symptoms and impact on quality of life
Nappi, R. E., & Lachowsky, M. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.03.021 · Cited by 296
Self-citationSelf-reported urogenital symptoms in postmenopausal women: Women’s Health Initiative
Pastore, L. M., Carter, R. A., Hulka, B. S., & Wells, E. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.06.019 · Cited by 210
Graziottin, A., & Leiblum, S. R. (2005) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2005.00129.x · Cited by 182
Effective Treatment of Vaginal Atrophy With an Ultra–Low-Dose Estradiol Vaginal Tablet
Simon, J. A., Nachtigall, L. E., Gut, R., Lang, E., Archer, D. F., & Utian, W. H. (2008) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31818aa7c3 · Cited by 154
Efficacy and tolerability of local estrogen therapy for urogenital atrophy
Archer, D. F. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181a95581 · Cited by 142
Continuing Medical Education: The Use of Estrogen Therapy in Women’s Sexual Functioning (CME)
Nappi, R. E., & Polatti, F. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01198.x · Cited by 108
Self-citationMinimized estradiol absorption with ultra-low-dose 10 μg 17β-estradiol vaginal tablets
Eugster-Hausmann, M., Waitzinger, J., & Lehnick, D. (2010) · Climacteric · doi:10.3109/13697137.2010.483297 · Cited by 107
Attitudes, perceptions and knowledge about the vagina: the International Vagina Dialogue Survey
Nappi, R. E., Liekens, G., & Brandenburg, U. (2006) · Contraception · doi:10.1016/j.contraception.2005.12.007 · Cited by 57
Self-citationEndometrial safety of ultra-low-dose Vagifem 10 μg in postmenopausal women with vaginal atrophy
Ulrich, L. S. G., Naessén, T., Elia, D., Goldstein, J. A., Eugster-Hausmann, M., & on behalf of the VAG-1748 trial investigators (2010) · Climacteric · doi:10.3109/13697137.2010.481058 · Cited by 49
Recent advances in hormone replacement therapy.
Smith, R., & Studd, J. W. W. (1993) · PubMed · Cited by 31
Progress and Prospects in Treating Postmenopausal Vaginal Atrophy
Winneker, R. C., & Harris, H. A. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.161 · Cited by 23
Cited by
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Symptoms of menopause — global prevalence, physiology and implications
Monteleone, P., Mascagni, G., Giannini, A., Genazzani, A. R., & Simoncini, T. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.180 · Cited by 810
Portman, D. J., & Gass, M. L. S. (2014) · Menopause · doi:10.1097/gme.0000000000000329 · Cited by 688
Understanding weight gain at menopause
Davis, S. R., Castelo-Branco, C., Chedraui, P., Lumsden, M. A., Nappi, R. E., Shah, D., Villaseca, P., & as the Writing Group of the International Menopause Society for World Menopause Day 2012 (2012) · Climacteric · doi:10.3109/13697137.2012.707385 · Cited by 604
Self-citation(2013) · Menopause · doi:10.1097/gme.0b013e3182a122c2 · Cited by 560
Metadata
- Authors
- Nappi, R. E., & Kokot-Kierepa, M.
- Venue
- Climacteric
- Publisher
- Informa UK Limited
- Published
- 2011-12-14
- Volume
- 15
- Issue
- 1
- Pages
- 36-44
- ISSN
- 1369-7137 (ISSN-L)
- 1473-0804
- OpenAlex
- W1973157699
- Cited by
- 407
- References
- 18
- FWCI
- 13.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.